Maravai LifeSciences Holdings, Inc. (MRVI) Free Cash Flow
Maravai LifeSciences Holdings, Inc. (MRVI) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2021-12-31 | $353.72M |
| 2022-12-31 | $518.89M |
| 2023-12-31 | $60.67M |
| 2024-12-31 | -$22.19M |
| 2025-12-31 | -$70.72M |
How MRVI compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| DYAI | Dyadic International Inc. | -$5.70M |
| SPRO | Spero Therapeutics Inc. | -$12.62M |
| HRTX | Heron Therapeutics Inc. | -$27.91M |
| IART | Integra LifeSciences Holdings Corporation | -$45.25M |
| FLGT | Fulgent Genetics Inc. | -$124.21M |
These are five companies in the same sector as MRVI with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Maravai LifeSciences Holdings, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("MRVI", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | MRVI | $7.68 | -8.24% | 5.56M |
| 3 | ||||
| 4 | ||||
| 5 |